4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-22-007001
Options or other derivatives
- Director acquired 7,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| CARTER BRUCE L A Director | 2022-03-03 | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | D: show line 1 in the form |
Loading xslF345X03/form4.xml…